Pathological splenic rupture: A rare complication of chronic myelomonocytic leukemia

American Journal of Hematology

Volumn 82, Issue 5, 2007, Pages 405-408

  Goddard, Shannon Lynn ^a   Chesney, Alden E ^a   Reis, Marciano D ^a   Ghorab, Zeina ^a   Brzozowski, Mike ^a   Wright, Frances C ^a   Wells, Richard A ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic myelomonocytic leukemia; Complications; Myelodysplastic syndrome; Splenic rupture

Indexed keywords

HEMOGLOBIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BLAST CELL; CASE REPORT; CELL LINEAGE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CONVALESCENCE; DISEASE SEVERITY; EMERGENCY SURGERY; EMERGENCY WARD; HUMAN; MALE; MONOCYTOSIS; MYELODYSPLASTIC SYNDROME; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RARE DISEASE; SPLEEN RUPTURE; SPLENECTOMY; SPLENOMEGALY;

ABDOMEN, ACUTE; EMERGENCIES; HEMOPERITONEUM; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKEMIC INFILTRATION; MALE; MIDDLE AGED; RUPTURE, SPONTANEOUS; SPLEEN; SPLENECTOMY; SPLENIC RUPTURE; SPLENOMEGALY;

EID: 34247483531     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20812     Document Type: Article

References (14)

1. Maslak P, McKenzie S. Chronic myelomonocytic leukemia. Blood 2003;102:3863.
2. Yavorkovsky LL, Cook P. Classifying chronic myelomonocytic leukemia. J Clin Oncol 2001;19:3790-3792.
3. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-2302.
4. Nosslinger T, Reisner R, Gruner H, Tuchler H, Nowotny H, Pittermann E, et al. Dysplastic versus proliferative CMML - A retrospective analysis of 91 patients from a single institution. Leuk Res 2001;25:741-747.
5. Gonzalez-Medina I, Bueno J, Torrequebrada A, Lopez A, Vallespi T, Massague I. Two groups of chronic myelomonocytic leukaemia: Myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center. Leuk Res 2002;26:821-824.
6. Voglova J, Chrobak L, Neuwirtova R, Malaskova V, Straka L. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia-distinct subgroups or two stages of the same disease? Leuk Res 2001;25:493-499.
7. Bauer TW, Haskins GE, Armitage RD. Splenic rupture in patients with hematologic malignancies. Cancer 1981;48:2729-2733.
8. Giagounidis AA, Burk M, Meckenstock G, Koch AJ, Schneider W. Pathologic rupture of the spleen in hematologic malignancies: Two additional cases. Ann Hematol 1996;73:297-302.
9. Steensma DP, Tefferi A, Li RD. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: Reinforcement of the heterogeneity of the syndrome. Leuk Res 2003;27:775-782.
10. Jimenez Herraez MC, Larrocha Rabanal C, Fernandez de Castro M, Viloria Vicente A. [Pathological rupture of the spleen in a case of chronic myelomonocytic leukemia]. Sangre (Barc) 1991;36:168.
11. Diebold J, Audouin J. Peliosis of the spleen. Report of a case associated with chronic myelomonocytic leukemia, presenting with spontaneous splenic rupture. Am J Surg Pathol 1983;7:197-204.
12. Elliott MA, Mesa RA, Tefferi A. Adverse events after imatinib mesylate therapy. N Engl J Med 2002;346:712-723.
13. Gologan R, Berceanu A, Colita A, Codreanu V, Dobrea C, Geoada L, et al. Clinical and hematological aspects of chronic myelomonocytic leukemia. Study on 20 cases from a single center from Romania. Rom J Intern Med 2002;40(1-4):95-102.
14. Grover SA, Barkun AN, Sackett RD. The rational clinical examination. Does this patient have splenomegaly? JAMA 1993; 270:2218-2221.